# EDGAR Filing Document

**Accession Number:** 0001685316
**File Stem:** 0001193125-23-082222
**Filing Date:** 2023-3
**Character Count:** 6779
**Document Hash:** 3e754b2eaa735b2b756e1f780dbbd0f9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-082222.hdr.sgml**: 20230328

**ACCESSION NUMBER**: 0001193125-23-082222

**CONFORMED SUBMISSION TYPE**: S-8 POS

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230328

**DATE AS OF CHANGE**: 20230328

**EFFECTIVENESS DATE**: 20230328

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ObsEva SA
- **CENTRAL INDEX KEY:** 0001685316
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** V8
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8 POS
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-263234
- **FILM NUMBER:** 23770005

**BUSINESS ADDRESS:**
- **STREET 1:** CHEMIN DES AULX, 12
- **CITY:** PLAN-LES-OUATES
- **STATE:** V8
- **ZIP:** 1228
- **BUSINESS PHONE:** 0041-0-22-552-1558

**MAIL ADDRESS:**
- **STREET 1:** CHEMIN DES AULX, 12
- **CITY:** PLAN-LES-OUATES
- **STATE:** V8
- **ZIP:** 1228

**As filed with the Securities and Exchange Commission on March 28, 2023** 

**Registration No. 333-263234** 

**Registration No. 333-249457** 

**Registration No. 333-231629** 

**Registration No. 333-216170** 

------

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**WASHINGTON, D.C. 20549** 

------

**POST-EFFECTIVE AMENDMENT NO. 1 TO:** 

**Form S-8 Registration No. 333-263234** 

**Form S-8 Registration No. 333-249457** 

**Form S-8 Registration No. 333-231629** 

**Form S-8 Registration No. 333-216170** 

***UNDER***

***THE SECURITIES ACT OF 1933***

------

## OBSEVA SA
**(Exact name of Registrant as specified in its charter)** 

------

---

| | |
|:---|:---|
| **Switzerland** | **N/A** |
| **(State or other jurisdiction of**<br> **incorporation or organization)** | **(I.R.S. Employer**<br> **Identification No.)** |

---

**Chemin des Aulx, 12** 

**1228 Plan-les-Ouates** 

**Geneva, Switzerland** 

**Tel: +41 22 552 38 40** 

**(Address and telephone number, including area code of Registrant's principal executive offices)** 

------

**Cogency Global Inc.** 

**122 East 42nd Street, 18th Floor** 

**New York, New York 10168** 

**Tel: (212) 947-7200** 

**(Name, address, including zip code, and telephone number, of agent for service)** 

------

***Copies to:***

**Divakar Gupta** 

**Ryan Sansom** 

**Cooley LLP** 

**55 Hudson Yards** 

**New York, New York 10001** 

**Tel: (212) 479-6000** 

------

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
|  |  | Emerging growth company | ☐ |

---

------

**DEREGISTRATION OF SECURITIES** 

This Post-Effective Amendment No. 1 (this "***Post-Effective Amendment***") relates to the following Registration Statements on Form S-8 (each a "***Registration Statement***," and collectively, the "***Registration Statements***"), filed with the Securities and Exchange Commission (the "***SEC***") by ObsEva SA (the "***Registrant***"):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• [Registration Statement No. 333-263234, filed with the SEC on March 2, 2022](http://www.sec.gov/Archives/edgar/data/1685316/000119312522063069/d289489ds8.htm) , pertaining to the registration of 4,753,671 common shares of the Registrant reserved for future issuance under the 2017 Equity
Incentive Plan, as amended (the "  ***Plan*** ");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• [Registration Statement No. 333-249457, filed with the SEC on October 13, 2020](http://www.sec.gov/Archives/edgar/data/1685316/000119312520268457/d928842ds8.htm) , pertaining to the registration of 3,204,124 common shares of the Registrant reserved for future issuance under the Plan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• [Registration Statement No. 333-231629, filed with the SEC on May 21, 2019](http://www.sec.gov/Archives/edgar/data/1685316/000119312519151974/d746820ds8.htm) , pertaining to the registration of 1,749,995 common shares of the Registrant reserved for future issuance under the Plan; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• [Registration Statement No. 333-216170, filed with the SEC on February 22, 2017](http://www.sec.gov/Archives/edgar/data/1685316/000119312517052169/d350915ds8.htm) , pertaining to the registration of 4,172,623 common shares of the Registrant reserved for future issuance under the Plan.

The Registrant is filing this Post-Effective Amendment to deregister any and all securities that remain unsold under the Registration Statements as of the date hereof. In accordance with the undertakings made by the Registrant in the Registration Statements to remove from registration by means of a post-effective amendment any securities that had been registered for issuance but remain unsold at the termination of the offering, the Registrant hereby removes and withdraws from registration any and all securities registered pursuant to the Registration Statements that remain unsold as of the date hereof. Note that the numbers of securities listed above do not take into account any applicable corporate actions, such as stock splits, that may have been taken in the interim.

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment No. 1 to the Registration Statements on Form S-8 to be signed on its behalf by the undersigned, thereunto duly authorized, in Geneva, Switzerland, on March 28, 2023.

---

| | |
|:---|:---|
| **OBSEVA SA** | **OBSEVA SA** |
| By: | /s/ *Will Brown* |
|  | Will Brown, Interim Chief Executive Officer and Chief Financial Officer |

---

------

**SIGNATURE OF AUTHORIZED U.S. REPRESENTATIVE** 

Pursuant to the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of ObsEva SA, has signed this Post-Effective Amendment No. 1 to Registration Statements on Form S-8 on March 28, 2023.

---

| | |
|:---|:---|
| **Authorized U.S. Representative** – Cogency Global Inc. | **Authorized U.S. Representative** – Cogency Global Inc. |
| By: | */s/ Colleen A. DeVries*  |
|  | Name: Colleen A. DeVries |
|  | Title: Senior Vice-President on behalf of Cogency Global Inc. |

---